Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Intercept Pharma (NASDAQ: ICPT) and thinks there will be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE